SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 5/24/2017 12:00:41 AM - Followers: 1329 - Board type: Free - Posts Today: 1

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#211451  Sticky Note AKAO FDA Breakthrough designation Whalatane 05/23/17 07:37:42 PM
#211450  Sticky Note Re: Keytruda ciotera 05/23/17 05:21:50 PM
#211447  Sticky Note GLYC +23% on offering of 6.9M* shares that DewDiligence 05/23/17 03:15:02 PM
#211446  Sticky Note FDA approves Keytruda for solid tumors with high DewDiligence 05/23/17 03:07:50 PM
#211434  Sticky Note SNY/REGN—FDA approves Kevzara (sarilumab) for moderate-to-severe RA: DewDiligence 05/22/17 06:13:29 PM
#210691  Sticky Note MNTA—Interchangeable Humira FoB for US market is badly needed: DewDiligence 04/18/17 03:36:02 PM
#211456   Maybe, maybe not. No need to do an Superfly15 05/24/17 12:00:41 AM
#211455   PLSE , biocqr ..the most important part of Whalatane 05/23/17 11:43:56 PM
#211454   Any opinions on this source?No original content—just a DewDiligence 05/23/17 08:50:40 PM
#211453   AKAO—…as night follows day…Actually, the PR for the DewDiligence 05/23/17 08:48:07 PM
#211452   AKAO ...and as night follows day Whalatane 05/23/17 07:54:16 PM
#211451   AKAO FDA Breakthrough designation Whalatane 05/23/17 07:37:42 PM
#211450   Re: Keytruda ciotera 05/23/17 05:21:50 PM
#211449   Dew Re PLSE and Streetsweeper Whalatane 05/23/17 03:48:29 PM
#211448   Addendum on today's Keytruda approval: DewDiligence 05/23/17 03:20:44 PM
#211447   GLYC +23% on offering of 6.9M* shares that DewDiligence 05/23/17 03:15:02 PM
#211446   FDA approves Keytruda for solid tumors with high DewDiligence 05/23/17 03:07:50 PM
#211445   PLSE thx biocqr but I suggest Whalatane 05/23/17 01:55:53 PM
#211444   PLSE > Streetsweeper.... Shock Therapy Doesn't Cut It biocqr 05/23/17 01:07:33 PM
#211443   Maybe, maybe not. No need to do Maciste 05/23/17 12:21:34 PM
#211442   AUPH- Maciste, that is all well and good biotech_researcher 05/23/17 12:19:08 PM
#211441   You conveniently forgot to include the last sentence Maciste 05/23/17 12:15:14 PM
#211440   AUPH- Maciste, I did, you may have read biotech_researcher 05/23/17 12:04:52 PM
#211439   You may want to re-read the article about Maciste 05/23/17 08:54:52 AM
#211438   RVNC - Ticker Report - Any opinions on randychub 05/22/17 11:15:28 PM
#211436   AMGN down only 2% on Romosozumab safety signal; DewDiligence 05/22/17 08:01:37 PM
#211435   RVNC—PropThink has a write-up on the CD data DewDiligence 05/22/17 07:56:49 PM
#211434   SNY/REGN—FDA approves Kevzara (sarilumab) for moderate-to-severe RA: DewDiligence 05/22/17 06:13:29 PM
#211433   The confidential treatment concerns RVNC’s fill/finish agreement with DewDiligence 05/22/17 06:04:29 PM
#211432   Dew, Any opinion on the CT request that henrym28 05/22/17 05:49:24 PM
#211431   AUPH- HC Wainwright cuts AUPH price target due biotech_researcher 05/22/17 05:10:06 PM
#211430   According to ADXS, PFS at 3 years is DewDiligence 05/22/17 12:43:03 PM
#211429   Is there a standard PFS for locally advanced mr_o 05/22/17 12:09:21 PM
#211428   XBIO -5% on negative phase-2 results for SHP656—a DewDiligence 05/22/17 11:35:26 AM
#211427   AMGN cardio risk is a plus for rival DewDiligence 05/22/17 10:17:46 AM
#211426   PBYI +83%(!) on briefing docs for 5/24/17 ODAC: DewDiligence 05/22/17 10:14:21 AM
#211425   MNTA can't get a break- downgrade From jbog: Momenta downgraded biotech_researcher 05/22/17 09:48:07 AM
#211424   AMGN cardio risk is a plus for rival lgonber 05/22/17 03:43:37 AM
#211423   Really interesting and remarkably prescient. biomaven0 05/21/17 11:17:41 PM
#211422   This letter to the editor was unfortunately pretty dewophile 05/21/17 10:04:29 PM
#211421   AMGN—Evenity (romosozumab) BLA on hold due to CV-safety DewDiligence 05/21/17 08:55:27 PM
#211420   As of 3/31/17, 40mg Copaxone accounted for >85% DewDiligence 05/21/17 02:20:10 PM
#211419   Anyone have chart showing 20mg and 40mg Copaxone RioLobo 05/21/17 12:32:58 PM
#211418   Webcast Calendar ghmm 05/20/17 07:52:02 PM
#211417   Considering the quality of the drug, 6 month jbog 05/20/17 06:00:25 PM
#211416   That's cause you're using the Hebrew calendar, Aaron :) genisi 05/20/17 02:29:34 PM
#211415   5780 seems like a long way away. rkrw 05/20/17 12:50:50 PM
#211414   If I am reading the chart right, TEVA Rocky3 05/20/17 09:57:40 AM
#211413   The negative effect on daily and thrice-weekly Copaxone genisi 05/20/17 09:06:38 AM
#211412   Plantar's Fasciitis: IanFromSI 05/20/17 01:31:19 AM
#211411   That appears to be a 6-! stock - biomaven0 05/19/17 08:36:56 PM
#211410   NSPR: Up 0.91% today! Great Products News --- Value_Investor 05/19/17 04:29:13 PM
#211409   Thank you dew. At those dosage randychub 05/19/17 03:40:30 PM
#211408   Yes although w ovarian mets are generally very dewophile 05/19/17 03:37:04 PM
#211407   >>So this is just the opposite of what biomaven0 05/19/17 02:31:43 PM
#211406   It's too late now but Valeant would have jbog 05/19/17 01:58:29 PM
PostSubject